High Point Advisor Group LLC Neurocrine Biosciences Inc Transaction History
High Point Advisor Group LLC
- $1.84 Billion
- Q2 2025
A detailed history of High Point Advisor Group LLC transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, High Point Advisor Group LLC holds 2,871 shares of NBIX stock, worth $394,819. This represents 0.02% of its overall portfolio holdings.
Number of Shares
2,871
Previous 2,812
2.1%
Holding current value
$394,819
Previous $311,000
15.76%
% of portfolio
0.02%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding NBIX
# of Institutions
660Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$1.95 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.35 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$766 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$614 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$424 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.2B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...